Schantz S P, Liu F J
Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Cancer. 1989 Sep 15;64(6):1232-7. doi: 10.1002/1097-0142(19890915)64:6<1232::aid-cncr2820640612>3.0.co;2-u.
Numerous reports have suggested, although never demonstrated, a suppressed immune defense mechanism as a contributing factor in the development of head and neck cancer in the young adult. Twenty-four previously untreated adults less than or equal to 40 years of age with squamous cell carcinoma were examined for lymphocyte function (natural killer cell activity and in vitro lymphocyte blastogenesis response to mitogens), total lymphocyte number and percentage of lymphocyte subsets, and humoral immune status (circulating IgA, IgG, and IgM). As compared with 33 healthy young adults, no significant immunologic deficit could be identified. On the contrary, the young adult cancer population had significantly increased lymphocyte numbers (P less than 0.05) and serum IgA, IgG, and IgM levels (P less than 0.001, respectively). These young cancer patients cannot be considered to be immunosuppressed. Alternative biologic mechanisms must be defined to account for the increasing incidence of head and neck cancer over the last decade among young adults in the United States.
众多报告表明,尽管从未得到证实,但免疫防御机制受到抑制是导致年轻成年人头颈癌发病的一个因素。对24名年龄小于或等于40岁、此前未经治疗的鳞状细胞癌成年患者进行了淋巴细胞功能(自然杀伤细胞活性以及体外淋巴细胞对有丝分裂原的母细胞生成反应)、淋巴细胞总数及淋巴细胞亚群百分比,以及体液免疫状态(循环IgA、IgG和IgM)的检测。与33名健康的年轻成年人相比,未发现明显的免疫缺陷。相反,年轻成年癌症患者的淋巴细胞数量显著增加(P<0.05),血清IgA、IgG和IgM水平也显著升高(分别为P<0.001)。这些年轻癌症患者不能被视为免疫抑制。必须确定其他生物学机制来解释过去十年美国年轻成年人头颈癌发病率上升的现象。